✉news HealthMedicine first seen 3 h ago, last 2 h ago, peak #37
NIH trial finds antiviral drug fails to improve Long COVID symptoms
Original: Antiviral drug did not improve Long COVID symptoms
Researchers with the National Institutes of Health report that an antiviral drug did not improve symptoms in patients with Long COVID. The finding comes from a federally funded trial and adds to a string of disappointing results in the search for effective treatments for the lingering condition, which affects millions of people worldwide. Clinicians and patient advocates say the result underscores how little proven therapy exists for the illness.
Why now: Millions of Long COVID patients are waiting for effective treatments, so any major trial result draws wide attention.
National Institutes of HealthLong COVIDantiviral drug
Rank over time, top of the chart is #1. 2 snapshots from 3 h ago to 2 h ago.
Evidence
- Antiviral drug did not improve Long COVID symptoms · National Institutes of Health (NIH) | (.gov)
API: https://socialmediatrends-api.osmike.com/v1/trends/386704